SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-017983
Filing Date
2023-11-07
Accepted
2023-11-07 16:04:41
Documents
94
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q coll-20230930x10q.htm   iXBRL 10-Q 2435905
2 EX-31.1 coll-20230930xex31d1.htm EX-31.1 13081
3 EX-31.2 coll-20230930xex31d2.htm EX-31.2 13105
4 EX-32.1 coll-20230930xex32d1.htm EX-32.1 7664
5 EX-32.2 coll-20230930xex32d2.htm EX-32.2 7502
6 GRAPHIC coll-20230930x10q001.jpg GRAPHIC 9164
  Complete submission text file 0001558370-23-017983.txt   11856197

Data Files

Seq Description Document Type Size
7 EX-101.SCH coll-20230930.xsd EX-101.SCH 70180
8 EX-101.CAL coll-20230930_cal.xml EX-101.CAL 88683
9 EX-101.DEF coll-20230930_def.xml EX-101.DEF 297365
10 EX-101.LAB coll-20230930_lab.xml EX-101.LAB 591846
11 EX-101.PRE coll-20230930_pre.xml EX-101.PRE 472309
88 EXTRACTED XBRL INSTANCE DOCUMENT coll-20230930x10q_htm.xml XML 2603555
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37372 | Film No.: 231383614
SIC: 2834 Pharmaceutical Preparations